AbelZeta Pharma is a clinical-stage biopharmaceutical company developing CAR-T cell therapies and antibody-based immuno-oncology treatments, with operations in the US and China.
/PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development...
PR Newswire reports AbelZeta Pharma regained global rights to C-CAR039 (Prizlon-cel) and received FDA clearance of an IND application in large B-cell lymphoma.
BioSpace reports Johnson & Johnson returned rights to its lymphoma bispecific CAR-T therapy back to AbelZeta Pharma.